Delcath Systems, Inc. is a health device business focusing on treatment of cancer. We currently have no information about possible layoffs at Delcath.The Company is currently testing an advanced and proprietary, patented drug delivery system for the treatment of cancers (liver). Delcath's new drug delivery platform is testing the delivery of extremely high doses of anti-cancer drugs to the liver while preventing these high doses of drugs from entering the patient's body (aside from liver). The Company is enrolling patients in Phase III and Phase II clinical studies for the treatment of liver cancers using high doses of melphalan. Delcath's intellectual property portfolio consists of 27 patents on a worldwide basis including the USA, Europian Union, Canada and Asia. Delcath's website is located at delcath.com.
There are no replies in this thread yet. Be the first to post a reply below: